We have developed a target organism which permits quantitative bactericidal assays. The organism is an Escherichia coli mutant which cannot grow at the temperature of the assay (37°C), but retains full colony-forming potential for subsequent quantitation at 25°C. We show that quantitative data on the bactericidal capacity of polymorphonuclear leukocytes and alveolar macrophages can be obtained when this mutant is used as a target. The procedure used to generate the strain is described in detail and should be applicable to many bacterial species. Biologics, Bethesda, Md.). All incubations were in R broth, a complex medium containing yeast extract and tryptone (5). All platings were on G agar (M. P. Oeschger, J. Bacteriol., in press), except when otherwise indicated.
We have developed a target organism which permits quantitative bactericidal assays. The organism is an Escherichia coli mutant which cannot grow at the temperature of the assay (37°C), but retains full colony-forming potential for subsequent quantitation at 25°C. We show that quantitative data on the bactericidal capacity of polymorphonuclear leukocytes and alveolar macrophages can be obtained when this mutant is used as a target. The procedure used to generate the strain is described in detail and should be applicable to many bacterial species. Characterization of the properties of the mutant indicates that it has a strong potential for use in other in vivo and in vitro investigations of host responses to microbial invasion.
For many years bactericidal assays have been used, both experimentally and clinically, to determine the capacity of phagocytic cells to ingest and kill microorganisms. Problems exist in interpreting the results of these assays because of multiplication of the bacteria during the course of the assay. Attempts to improve the quantitation of the assay by inhibiting bacterial growth with sublethal concentrations of antibiotics (3, 4, 6, 9, 12) have only complicated the problem. The complication arises from the accumulation of lethal levels of antibiotics within the phagolysosomes (1, 2) . Under such conditions the killing of bacteria within the phagolysosomes by the antimicrobial mechanisms of the cells cannot be quantitated because it cannot be separated from the killing due to the antibiotic. A second approach to the minimization of background replication has been to reduce the incubation times of the assays. This approach makes it difficult to detect phagocytic or bactericidal activities of neonatal leukocytes and other slow or marginally competent cells. Other attempts to eliminate this problem have met with limited success (7, 11 Biologics, Bethesda, Md.). All incubations were in R broth, a complex medium containing yeast extract and tryptone (5). All platings were on G agar (M. P. Oeschger, J. Bacteriol., in press), except when otherwise indicated.
Mutagenesis and mutant isolation. Mutagenesis was performed by the method reported by Oeschger and Berlyn (8) . A freshly prepared solution of Nmethyl-N'-nitro-N-nitrosoguanidine (1 mg/ml in acetone) was added to a log-phase culture of E. coli to a final concentration of 10 jig/ml. The cells were incubated for 10 min at 37°C without aeration and then were washed twice with and resuspended in R broth. The resuspended cells were diluted to 20 times the initial volume and incubated overnight at 22°C to allow segregation of the induced mutations.
The enrichments were performed as shown in Fig.   1 . The segregated cultures were diluted with R broth and incubated at 22°C. Once logarithmic growth was established, the cultures were transferred to 35°C and penicillin was immediately added to a final concentration of 5,000 U/ml. After 3 h of incubation, the penicillin was inactivated by adding penicillinase (final concentration, 10,000 U/ml) for 30 min at 35°C. The cultures were then washed, resuspended in fresh R broth, and incubated overnight at 22°C. D-Cycloserine at a final concentration of 2 mM was used for the second enrichment. The Surface antigenicity. E. coli strain Easter possesses a characteristic set of surface antigens. To determine whether the major cross-reacting antigen had been altered as a result of mutagenesis, the mutant and its parent were grown on agar containing antiserum to that antigen (10) . Using the monolayer method described by Zeligs et al. (13), we compared susceptibility of the mutant to phagocytosis with that of its parent.
Bactericidal assays. Human polymorphonuclear leukocytes (PMN) and rabbit alveolar macrophages were used for bactericidal assays. Purified suspensions of PMN were obtained by dextran sedimentation of heparinized venous blood. Contaminating erythrocytes were removed by hypotonic lysis, and the leukocytes were washed and suspended in modified Krebs-Ringers phosphate buffer (14) . The target bacteria, which consisted of suspensions of either mutant or parent strains, were prepared from overnight broth cultures grown at 25°C (mutant) or 37°C (parent). The cells were collected by centrifugation at 4°C and resuspended at the desired density in Krebs-Ringers phosphate buffer containing 8% pooled fresh human serum. The parent strain was held at 4°C while the mutant was incubated for 1 h at 37°C to ensure complete arrest of bacterial growth. Equal volumes of the PMN and bacterial suspensions were mixed to a final cell ratio of 1:4 in 1 ml. Control incubations were carried out using the bacterial suspensions alone. The assays were performed in triplicate at 37°C in sterile, siliconized, polypropylene tubes (Falcon Plastics, Oxnard, Calif.) on a Fisher Roto-Rack (10 rpm). Portions were removed at 0, 1, and 2 h, the phagocytes were lysed with distilled water, and serial dilutions of the lysates were plated and incubated at 25°C (mutant) or 37°C (parent) to determine the viable bacterial cell count. To demonstrate the value of using strain E/2/64 in a situation where the phagocytic cell has less bactericidal capacity than the PMN, both mutant and parent strains were compared in an assay with alveolar macrophages. Macrophages obtained from adult New Zealand white rabbits by tracheobronchial lavage were prepared as previously described (14) . The micro-bactericidal assay used has been described in detail by Zeligs et al. (13) .
Chemicals and reagents. N-methyl-N'-nitro-Nnitrosoguanidine was purchased from Aldrich, Milwaukee, Wis.; penicillin (as benzylpenicillin) and Dcycloserine were from Sigma Chemical Co., St. Fig. 1 . E/2/64 was chosen from the many isolates recovered after mutagenesis and enrichment because of both the rapidity with which it ceased to grow when the temperature was shifted to 35°C and its quick recovery after the temperature was returned to 250C. A typical growth inhibition experiment with the mutant and its parent is shown in Fig. 2 indicate that the mutant and its parent are equally susceptible to phagocytosis by human PMN.
Evaluation of E/2/64 as a target in bactericidal assays. Two different systems were employed to determine the value of E/2/64 as a target organism in bactericidal assays. Phagocytic cells of characteristically high and low bactericidal potential were utilized. Figure 3 compares the wild type and the mutant in an assay with human PMN, cells that normally show high bactericidal activity. Figure 3a shows that the parent strain, after dilution from overnight culture, goes through a typical lag phase before beginning exponential growth. The bactericidal activity of PMN can be measured during this lag period. However, once the cells begin logarithmic growth, quantitation becomes increasingly difficult. When the mutant is used as a target, bacterial replication is restricted and bactericidal activity is readily quantitated even in extended incubations (Fig. 3b) . Figure 4 clearly shows the value of E/2/64 as a target in a bactericidal assay system employing phagocytes whose bactericidal capacity is relatively low compared with that of PMN. The parent cannot be used as a target in this system (Fig. 4a) . Figure 4b , however, shows that the quantitation ofalveolar macrophage bactericidal activity can easily be made when E/2/64 is the target organism.
Further characterization of the mutant. The effect ofthe temperature-sensitive mutation on protein and ribonucleic acid synthesis was investigated. Table 2 shows that protein synthesis is rapidly inhibited in the mutant strain, with up to 98% inhibition within 3 min of transfer to 370C. The inhibition of ribonucleic acid synthesis was only 70 to 80% after 3 min and 85 to 90% after 20 min. These results indicate that the direct effect of the mutation is on protein synthesis.
We then determined the ability of the mutant to survive prolonged incubations at the restrictive temperature. Figure 5 shows that the mutant can survive up to 48 h of aerobic incubation at 370C in Krebs-Ringers phosphate buffer containing 5% heat-inactivated calf serum without significant loss of colony-forming potential. Sim- Properties of the mutant. The mutant E/2/64 rapidly ceases growth when the temperature is raised to 34°C and resumes growth when the temperature is returned to 250C. The strain retains full colony-forming potential for long periods of incubation at the restrictive temperature. Reversion analysis suggests that a single mutation is responsible for the temperature sensitivity. The lesion apparently affects an essential function, for growth cannot be restored at the nonpermissive temperature by the addition of nutritional factors. Other significant mutations resulting from treatment with nitrosoguanidine have not been detected. More importantly, the surface antigenicity and susceptibility to the bactericidal activity of phagocytic cells remain unchanged.
Applications. The temperature-sensitive mutant E/2/64 is an ideal target organism for bactericidal assays. Complications introduced by adding antibiotics to arrest the growth of bacteria during the assay are avoided. When necessary, assays can be carried out for prolonged periods without the background overwhelming the experimental results. This mutant has allowed the study of the appearance of bactericidal activity in rabbit alveolar macrophages during postnatal development (13) . E/2/64 can be exploited for other in vitro and in vivo experiments. The replication of the bacterium is blocked at the body temperature of most experimental animals, and E/2/64 can therefore be used for investigations with whole animals. The role of bacterial replication in the induction of host responses to microbial invasion can be evaluated by comparative studies with E/2/64 and its parent strain. The properties of E/2/64 make it eminently suitable for use in the further dissection of these responses at both the in vivo and in vitro levels.
